[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fDy5BnJk1cTjUebK6P3vE7OS2WqQGH7TjYlVd5TocwNM":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":58,"rows":65},"Khyber Medical University Peshawar",[4],44,false,17,1,17194,7,27,[14,17,19,22,24,26,28,30],{"name":15,"count":16},"Dental Plaque",3,{"name":18,"count":16},"PCOS",{"name":20,"count":21},"Obesity",2,{"name":23,"count":21},"Insulin Resistance",{"name":25,"count":21},"Inflammation",{"name":27,"count":21},"Stunting",{"name":29,"count":21},"Wasting",{"name":31,"count":21},"Gestational Diabetes",[33,38,43,48,53],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT07440784","Impact Of Intermittent And Water-Only Fasting On Gene Expression And Tumor Markers In Breast Cancer","2023-07-31","Conventional Chemotherapy",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT07119840","Comparison Of Clinical Effects Of Listerine And Chlorhexidine Mouth Wash In Patients Undergoing Fixed Orthodontic Treatment","2025-11-29","Listerine Mouthwash Product",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT07242612","Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis","2026-03-25","Alendronate, Ibandronate; Risedronate",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT07187661","Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic Synovitis","2026-03-28","Intra-articular Bevacizumab",{"nctId":54,"briefTitle":55,"date":56,"intervention":57},"NCT07336914","Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes","2026-03-30","Dietary intervention + Physical Activity + Monitoring",[59,60,61,62,63,64],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[66,91,112,134,152,174,192,213,242,281,306,324,342,360,384,410,435,461,515,542,560,586],{"intervention":52,"totalTrials":9,"cells":67},{"EARLY_PHASE1":68,"PHASE1":71,"PHASE2":73,"PHASE3":75,"PHASE4":77,"NA":79},{"trials":69,"activeCount":70},[],0,{"trials":72,"activeCount":70},[],{"trials":74,"activeCount":70},[],{"trials":76,"activeCount":70},[],{"trials":78,"activeCount":70},[],{"trials":80,"activeCount":9,"soonestReadout":51},[81],{"nctId":49,"briefTitle":50,"status":82,"phases":83,"primaryCompletion":51,"completion":84,"start":85,"enrollment":86,"conditions":87,"interventions":90},"RECRUITING",[64],"2026-04-15","2025-09-09",25,[88,89],"Hemophilia","Chronic Synovitis",[52],{"intervention":57,"totalTrials":9,"cells":92},{"EARLY_PHASE1":93,"PHASE1":95,"PHASE2":97,"PHASE3":99,"PHASE4":101,"NA":103},{"trials":94,"activeCount":70},[],{"trials":96,"activeCount":70},[],{"trials":98,"activeCount":70},[],{"trials":100,"activeCount":70},[],{"trials":102,"activeCount":70},[],{"trials":104,"activeCount":9,"soonestReadout":56},[105],{"nctId":54,"briefTitle":55,"status":82,"phases":106,"primaryCompletion":56,"completion":107,"start":108,"enrollment":109,"conditions":110,"interventions":111},[64],"2026-04-25","2025-10-01",60,[31],[57],{"intervention":47,"totalTrials":9,"cells":113},{"EARLY_PHASE1":114,"PHASE1":116,"PHASE2":118,"PHASE3":120,"PHASE4":122,"NA":124},{"trials":115,"activeCount":70},[],{"trials":117,"activeCount":70},[],{"trials":119,"activeCount":70},[],{"trials":121,"activeCount":70},[],{"trials":123,"activeCount":70},[],{"trials":125,"activeCount":9,"soonestReadout":46},[126],{"nctId":44,"briefTitle":45,"status":82,"phases":127,"primaryCompletion":46,"completion":84,"start":108,"enrollment":128,"conditions":129,"interventions":132},[64],40,[130,131],"Osteoporosis","Osteoporosis, Postmenopausal",[47,133],"Teriparatide",{"intervention":133,"totalTrials":9,"cells":135},{"EARLY_PHASE1":136,"PHASE1":138,"PHASE2":140,"PHASE3":142,"PHASE4":144,"NA":146},{"trials":137,"activeCount":70},[],{"trials":139,"activeCount":70},[],{"trials":141,"activeCount":70},[],{"trials":143,"activeCount":70},[],{"trials":145,"activeCount":70},[],{"trials":147,"activeCount":9,"soonestReadout":46},[148],{"nctId":44,"briefTitle":45,"status":82,"phases":149,"primaryCompletion":46,"completion":84,"start":108,"enrollment":128,"conditions":150,"interventions":151},[64],[130,131],[47,133],{"intervention":42,"totalTrials":9,"cells":153},{"EARLY_PHASE1":154,"PHASE1":156,"PHASE2":158,"PHASE3":160,"PHASE4":162,"NA":164},{"trials":155,"activeCount":70},[],{"trials":157,"activeCount":70},[],{"trials":159,"activeCount":70},[],{"trials":161,"activeCount":70},[],{"trials":163,"activeCount":70},[],{"trials":165,"activeCount":9,"soonestReadout":41},[166],{"nctId":39,"briefTitle":40,"status":82,"phases":167,"primaryCompletion":41,"completion":168,"start":169,"enrollment":109,"conditions":170,"interventions":172},[64],"2025-12-30","2025-08-01",[171,15],"Gingivitis",[42,173],"Chlorhexidine mouthwash",{"intervention":173,"totalTrials":9,"cells":175},{"EARLY_PHASE1":176,"PHASE1":178,"PHASE2":180,"PHASE3":182,"PHASE4":184,"NA":186},{"trials":177,"activeCount":70},[],{"trials":179,"activeCount":70},[],{"trials":181,"activeCount":70},[],{"trials":183,"activeCount":70},[],{"trials":185,"activeCount":70},[],{"trials":187,"activeCount":9,"soonestReadout":41},[188],{"nctId":39,"briefTitle":40,"status":82,"phases":189,"primaryCompletion":41,"completion":168,"start":169,"enrollment":109,"conditions":190,"interventions":191},[64],[171,15],[42,173],{"intervention":37,"totalTrials":9,"cells":193},{"EARLY_PHASE1":194,"PHASE1":196,"PHASE2":198,"PHASE3":200,"PHASE4":202,"NA":204},{"trials":195,"activeCount":70},[],{"trials":197,"activeCount":70},[],{"trials":199,"activeCount":70},[],{"trials":201,"activeCount":70},[],{"trials":203,"activeCount":70},[],{"trials":205,"activeCount":9,"soonestReadout":36},[206],{"nctId":34,"briefTitle":35,"status":207,"phases":208,"primaryCompletion":36,"completion":56,"start":209,"enrollment":109,"conditions":210,"interventions":212},"ACTIVE_NOT_RECRUITING",[64],"2022-08-01",[211],"Breast Cancer",[37],{"intervention":214,"totalTrials":9,"cells":215},"Ribavirin",{"EARLY_PHASE1":216,"PHASE1":218,"PHASE2":220,"PHASE3":222,"PHASE4":238,"NA":240},{"trials":217,"activeCount":70},[],{"trials":219,"activeCount":70},[],{"trials":221,"activeCount":70},[],{"trials":223,"activeCount":70},[224],{"nctId":225,"briefTitle":226,"status":227,"phases":228,"primaryCompletion":229,"completion":230,"start":231,"enrollment":232,"conditions":233,"interventions":237},"NCT06744777","The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever","COMPLETED",[62],"2025-04-28","2025-05-29","2024-12-17",284,[234,235,236],"Dengue Fever","Dengue Hemorrhagic Fever","Severe Dengue",[214],{"trials":239,"activeCount":70},[],{"trials":241,"activeCount":70},[],{"intervention":243,"totalTrials":21,"cells":244},"Resveratrol",{"EARLY_PHASE1":245,"PHASE1":247,"PHASE2":249,"PHASE3":275,"PHASE4":277,"NA":279},{"trials":246,"activeCount":70},[],{"trials":248,"activeCount":70},[],{"trials":250,"activeCount":70},[251,265],{"nctId":252,"briefTitle":253,"status":227,"phases":254,"primaryCompletion":255,"completion":256,"start":257,"enrollment":258,"conditions":259,"interventions":261},"NCT06131918","Assessment of Antioxidant Therapy on Oxidative Stress Biomarkers in Type 2 Diabetic Patients With Neuropathy",[61],"2023-12-22","2024-05-05","2023-01-09",100,[260],"Peripheral Diabetic Neuropathy",[262,243,263,264],"Resveratrol, Alpha lipoic acid, Super oxide dismutase","Alpha lipoic acid","Super Oxide Dismutase",{"nctId":266,"briefTitle":267,"status":227,"phases":268,"primaryCompletion":269,"completion":269,"start":270,"enrollment":271,"conditions":272,"interventions":273},"NCT04867252","Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome",[61],"2021-08-03","2021-05-03",88,[18],[243,274],"Metformin",{"trials":276,"activeCount":70},[],{"trials":278,"activeCount":70},[],{"trials":280,"activeCount":70},[],{"intervention":282,"totalTrials":9,"cells":283},"Psilocybin",{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":300,"PHASE4":302,"NA":304},{"trials":285,"activeCount":70},[],{"trials":287,"activeCount":70},[],{"trials":289,"activeCount":70},[290],{"nctId":291,"briefTitle":292,"status":227,"phases":293,"primaryCompletion":294,"completion":295,"start":296,"enrollment":109,"conditions":297,"interventions":299},"NCT06746441","Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers",[61],"2025-06-01","2025-07-30","2024-12-01",[298],"Major Depressive Disorder",[282],{"trials":301,"activeCount":70},[],{"trials":303,"activeCount":70},[],{"trials":305,"activeCount":70},[],{"intervention":262,"totalTrials":9,"cells":307},{"EARLY_PHASE1":308,"PHASE1":310,"PHASE2":312,"PHASE3":318,"PHASE4":320,"NA":322},{"trials":309,"activeCount":70},[],{"trials":311,"activeCount":70},[],{"trials":313,"activeCount":70},[314],{"nctId":252,"briefTitle":253,"status":227,"phases":315,"primaryCompletion":255,"completion":256,"start":257,"enrollment":258,"conditions":316,"interventions":317},[61],[260],[262,243,263,264],{"trials":319,"activeCount":70},[],{"trials":321,"activeCount":70},[],{"trials":323,"activeCount":70},[],{"intervention":263,"totalTrials":9,"cells":325},{"EARLY_PHASE1":326,"PHASE1":328,"PHASE2":330,"PHASE3":336,"PHASE4":338,"NA":340},{"trials":327,"activeCount":70},[],{"trials":329,"activeCount":70},[],{"trials":331,"activeCount":70},[332],{"nctId":252,"briefTitle":253,"status":227,"phases":333,"primaryCompletion":255,"completion":256,"start":257,"enrollment":258,"conditions":334,"interventions":335},[61],[260],[262,243,263,264],{"trials":337,"activeCount":70},[],{"trials":339,"activeCount":70},[],{"trials":341,"activeCount":70},[],{"intervention":264,"totalTrials":9,"cells":343},{"EARLY_PHASE1":344,"PHASE1":346,"PHASE2":348,"PHASE3":354,"PHASE4":356,"NA":358},{"trials":345,"activeCount":70},[],{"trials":347,"activeCount":70},[],{"trials":349,"activeCount":70},[350],{"nctId":252,"briefTitle":253,"status":227,"phases":351,"primaryCompletion":255,"completion":256,"start":257,"enrollment":258,"conditions":352,"interventions":353},[61],[260],[262,243,263,264],{"trials":355,"activeCount":70},[],{"trials":357,"activeCount":70},[],{"trials":359,"activeCount":70},[],{"intervention":361,"totalTrials":9,"cells":362},"Metformin, pioglitazone and placebo",{"EARLY_PHASE1":363,"PHASE1":365,"PHASE2":367,"PHASE3":378,"PHASE4":380,"NA":382},{"trials":364,"activeCount":70},[],{"trials":366,"activeCount":70},[],{"trials":368,"activeCount":70},[369],{"nctId":370,"briefTitle":371,"status":227,"phases":372,"primaryCompletion":373,"completion":373,"start":374,"enrollment":375,"conditions":376,"interventions":377},"NCT04113889","Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome",[61],"2020-01-30","2019-10-15",147,[18],[274,361],{"trials":379,"activeCount":70},[],{"trials":381,"activeCount":70},[],{"trials":383,"activeCount":70},[],{"intervention":385,"totalTrials":9,"cells":386},"Acetyl-l-carnitine, folic acid",{"EARLY_PHASE1":387,"PHASE1":389,"PHASE2":391,"PHASE3":404,"PHASE4":406,"NA":408},{"trials":388,"activeCount":70},[],{"trials":390,"activeCount":70},[],{"trials":392,"activeCount":70},[393],{"nctId":394,"briefTitle":395,"status":227,"phases":396,"primaryCompletion":397,"completion":398,"start":399,"enrollment":400,"conditions":401,"interventions":403},"NCT05616000","Comparison of Acetyl- L- Carnitine& Folic Acid Versus Coenzyme Q10& Folic Acid on Semen& Hormonal Parameters& Semen Oxidative Status in Patients of Primary Infertility. A Double Blind Randomized Clinical Trial",[61],"2022-11-28","2022-11-29","2022-08-06",86,[402],"Infertility",[385],{"trials":405,"activeCount":70},[],{"trials":407,"activeCount":70},[],{"trials":409,"activeCount":70},[],{"intervention":411,"totalTrials":9,"cells":412},"OLIVE OIL 5ML\u002F5MG",{"EARLY_PHASE1":413,"PHASE1":415,"PHASE2":417,"PHASE3":429,"PHASE4":431,"NA":433},{"trials":414,"activeCount":70},[],{"trials":416,"activeCount":70},[],{"trials":418,"activeCount":70},[419],{"nctId":420,"briefTitle":421,"status":227,"phases":422,"primaryCompletion":423,"completion":424,"start":425,"enrollment":271,"conditions":426,"interventions":428},"NCT05952349","Effect of Metformin and Combination of Olive Oil Plus Nutritional Supplements on Inflammatory Markers IL-6 and IL-8 in PCOS.",[61],"2023-12-31","2024-04-01","2023-07-01",[427],"PCO",[411,274],{"trials":430,"activeCount":70},[],{"trials":432,"activeCount":70},[],{"trials":434,"activeCount":70},[],{"intervention":436,"totalTrials":9,"cells":437},"Metformin, Pioglitazone",{"EARLY_PHASE1":438,"PHASE1":451,"PHASE2":453,"PHASE3":455,"PHASE4":457,"NA":459},{"trials":439,"activeCount":70},[440],{"nctId":441,"briefTitle":442,"status":227,"phases":443,"primaryCompletion":444,"completion":445,"start":446,"enrollment":447,"conditions":448,"interventions":450},"NCT03117517","Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome",[59],"2017-08-29","2018-03-07","2017-03-20",106,[449],"Polycystic Ovarian Syndrome",[274,436],{"trials":452,"activeCount":70},[],{"trials":454,"activeCount":70},[],{"trials":456,"activeCount":70},[],{"trials":458,"activeCount":70},[],{"trials":460,"activeCount":70},[],{"intervention":274,"totalTrials":462,"cells":463},6,{"EARLY_PHASE1":464,"PHASE1":470,"PHASE2":472,"PHASE3":486,"PHASE4":488,"NA":490},{"trials":465,"activeCount":70},[466],{"nctId":441,"briefTitle":442,"status":227,"phases":467,"primaryCompletion":444,"completion":445,"start":446,"enrollment":447,"conditions":468,"interventions":469},[59],[449],[274,436],{"trials":471,"activeCount":70},[],{"trials":473,"activeCount":70},[474,478,482],{"nctId":266,"briefTitle":267,"status":227,"phases":475,"primaryCompletion":269,"completion":269,"start":270,"enrollment":271,"conditions":476,"interventions":477},[61],[18],[243,274],{"nctId":370,"briefTitle":371,"status":227,"phases":479,"primaryCompletion":373,"completion":373,"start":374,"enrollment":375,"conditions":480,"interventions":481},[61],[18],[274,361],{"nctId":420,"briefTitle":421,"status":227,"phases":483,"primaryCompletion":423,"completion":424,"start":425,"enrollment":271,"conditions":484,"interventions":485},[61],[427],[411,274],{"trials":487,"activeCount":70},[],{"trials":489,"activeCount":70},[],{"trials":491,"activeCount":70},[492,503],{"nctId":493,"briefTitle":494,"status":227,"phases":495,"primaryCompletion":496,"completion":497,"start":498,"enrollment":499,"conditions":500,"interventions":501},"NCT05653895","Independent and Additive Effects Of Micronutrients With Metformin In Patients With PCOS",[64],"2023-12-30","2024-02-07","2022-12-07",120,[18],[274,502],"Acetyl-L-Carnitin, L Arginine, Co-Q10",{"nctId":504,"briefTitle":505,"status":227,"phases":506,"primaryCompletion":507,"completion":508,"start":509,"enrollment":499,"conditions":510,"interventions":513},"NCT05767515","The Effects of Acetyl-L-Carnitine and Myo\u002FChiro-Inositol in Patients With PCOS",[64],"2024-02-25","2024-03-10","2023-07-15",[511,512],"Infertility, Female","PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries",[514],"metformin",{"intervention":516,"totalTrials":9,"cells":517},"Chlorhexidine Varnish",{"EARLY_PHASE1":518,"PHASE1":520,"PHASE2":522,"PHASE3":524,"PHASE4":526,"NA":528},{"trials":519,"activeCount":70},[],{"trials":521,"activeCount":70},[],{"trials":523,"activeCount":70},[],{"trials":525,"activeCount":70},[],{"trials":527,"activeCount":70},[],{"trials":529,"activeCount":70},[530],{"nctId":531,"briefTitle":532,"status":227,"phases":533,"primaryCompletion":534,"completion":535,"start":536,"enrollment":537,"conditions":538,"interventions":541},"NCT07115784","Clinical Efficacy of Chlorhexidine Varnish in Reducing Gingival Hyperplasia, Plaque Accumulation, and White Spot Lesions in Orthodontic Patients",[64],"2026-01-15","2026-02-15","2025-07-21",22,[539,15,540],"Gingival Hyperplasia","Tooth Demineralization",[516],{"intervention":502,"totalTrials":9,"cells":543},{"EARLY_PHASE1":544,"PHASE1":546,"PHASE2":548,"PHASE3":550,"PHASE4":552,"NA":554},{"trials":545,"activeCount":70},[],{"trials":547,"activeCount":70},[],{"trials":549,"activeCount":70},[],{"trials":551,"activeCount":70},[],{"trials":553,"activeCount":70},[],{"trials":555,"activeCount":70},[556],{"nctId":493,"briefTitle":494,"status":227,"phases":557,"primaryCompletion":496,"completion":497,"start":498,"enrollment":499,"conditions":558,"interventions":559},[64],[18],[274,502],{"intervention":561,"totalTrials":9,"cells":562},"Moderate-Intensity Statins",{"EARLY_PHASE1":563,"PHASE1":565,"PHASE2":567,"PHASE3":569,"PHASE4":571,"NA":573},{"trials":564,"activeCount":70},[],{"trials":566,"activeCount":70},[],{"trials":568,"activeCount":70},[],{"trials":570,"activeCount":70},[],{"trials":572,"activeCount":70},[],{"trials":574,"activeCount":70},[575],{"nctId":576,"briefTitle":577,"status":227,"phases":578,"primaryCompletion":295,"completion":579,"start":580,"enrollment":581,"conditions":582,"interventions":584},"NCT06782243","Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome",[64],"2025-08-25","2024-12-20",190,[583],"Acute Coronary Syndrome",[561,585],"High-Intensity Statins",{"intervention":585,"totalTrials":9,"cells":587},{"EARLY_PHASE1":588,"PHASE1":590,"PHASE2":592,"PHASE3":594,"PHASE4":596,"NA":598},{"trials":589,"activeCount":70},[],{"trials":591,"activeCount":70},[],{"trials":593,"activeCount":70},[],{"trials":595,"activeCount":70},[],{"trials":597,"activeCount":70},[],{"trials":599,"activeCount":70},[600],{"nctId":576,"briefTitle":577,"status":227,"phases":601,"primaryCompletion":295,"completion":579,"start":580,"enrollment":581,"conditions":602,"interventions":603},[64],[583],[561,585]]